Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Long H. Ngo, Ph.D.

Co-Author

This page shows the publications co-authored by Long Ngo and Ellen McCarthy.
Connection Strength

1.432
  1. Schonberg MA, Li VW, Eliassen AH, Davis RB, LaCroix AZ, McCarthy EP, Rosner BA, Chlebowski RT, Hankinson SE, Marcantonio ER, Ngo LH. Accounting for individualized competing mortality risks in estimating postmenopausal breast cancer risk. Breast Cancer Res Treat. 2016 12; 160(3):547-562.
    View in: PubMed
    Score: 0.207
  2. Schonberg MA, Li VW, Eliassen AH, Davis RB, LaCroix AZ, McCarthy EP, Rosner BA, Chlebowski RT, Rohan TE, Hankinson SE, Marcantonio ER, Ngo LH. Performance of the Breast Cancer Risk Assessment Tool Among Women Age 75 Years and Older. J Natl Cancer Inst. 2016 Mar; 108(3).
    View in: PubMed
    Score: 0.194
  3. Schonberg MA, Marcantonio ER, Ngo L, Silliman RA, McCarthy EP. Does Life Expectancy Affect Treatment of Women Aged 80 and Older with Early Stage Breast Cancers? J Geriatr Oncol. 2012 Jan 01; 3(1):8-16.
    View in: PubMed
    Score: 0.148
  4. Wee CC, Huskey KW, Ngo LH, Fowler-Brown A, Leveille SG, Mittlemen MA, McCarthy EP. Obesity, race, and risk for death or functional decline among Medicare beneficiaries: a cohort study. Ann Intern Med. 2011 May 17; 154(10):645-55.
    View in: PubMed
    Score: 0.142
  5. Schonberg MA, Marcantonio ER, Ngo L, Li D, Silliman RA, McCarthy EP. Causes of death and relative survival of older women after a breast cancer diagnosis. J Clin Oncol. 2011 Apr 20; 29(12):1570-7.
    View in: PubMed
    Score: 0.140
  6. Schonberg MA, Marcantonio ER, Li D, Silliman RA, Ngo L, McCarthy EP. Breast cancer among the oldest old: tumor characteristics, treatment choices, and survival. J Clin Oncol. 2010 Apr 20; 28(12):2038-45.
    View in: PubMed
    Score: 0.131
  7. Iezzoni LI, Ngo LH, Li D, Roetzheim RG, Drews RE, McCarthy EP. Early stage breast cancer treatments for younger Medicare beneficiaries with different disabilities. Health Serv Res. 2008 Oct; 43(5 Pt 1):1752-67.
    View in: PubMed
    Score: 0.115
  8. Iezzoni LI, Ngo LH, Li D, Roetzheim RG, Drews RE, McCarthy EP. Treatment disparities for disabled medicare beneficiaries with stage I non-small cell lung cancer. Arch Phys Med Rehabil. 2008 Apr; 89(4):595-601.
    View in: PubMed
    Score: 0.114
  9. McCarthy EP, Ngo LH, Chirikos TN, Roetzheim RG, Li D, Drews RE, Iezzoni LI. Cancer stage at diagnosis and survival among persons with Social Security Disability Insurance on Medicare. Health Serv Res. 2007 Apr; 42(2):611-28.
    View in: PubMed
    Score: 0.107
  10. McCarthy EP, Ngo LH, Roetzheim RG, Chirikos TN, Li D, Drews RE, Iezzoni LI. Disparities in breast cancer treatment and survival for women with disabilities. Ann Intern Med. 2006 Nov 07; 145(9):637-45.
    View in: PubMed
    Score: 0.104
  11. Roetzheim RG, Chirikos TN, Wells KJ, McCarthy EP, Ngo LH, Li D, Drews RE, Iezzoni LI. Managed care and cancer outcomes for Medicare beneficiaries with disabilities. Am J Manag Care. 2008 May; 14(5):287-96.
    View in: PubMed
    Score: 0.029
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.